Researchers have developed a breakthrough method to detect inflammation in the body using positron emission tomography (PET) imaging. This innovative probe targets CD45, a marker abundantly expressed ...

A study published in the international journal Antioxidants suggests that l uteolin, an antioxidant found in broccoli and ...

An Oxford company which uses AI to develop cancer treatments has achieved further validation for its approach to tackling multiple tumours. Oxford Drug Design's colorectal cancer model study on mice ...

The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

Oxford Drug Design has reported positive results from an in vivo colorectal cancer model study on mice, which, it said, ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...